Trial Profile
Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy (EARTH)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Eplerenone (Primary)
- Indications Essential hypertension; Left ventricular hypertrophy
- Focus Biomarker; Therapeutic Use
- Acronyms EARTH
- 25 Jul 2013 New trial record